India Exchange Filings

Supriya Lifescience Q2 FY27 Earnings and Board Meeting Highlights

Supriya Lifescience Ltd approves Q2 FY27 results with revenue of ₹206.30 crore and net profit of ₹29.25 crore.

  • Revenue rose 8.7% sequentially and 3.2% year on year; net profit increased 21.7% sequentially and declined 42.0% year on year.
  • Derived EBIT margin was 17.4%; no exceptional items were reported.
  • Auditor’s limited review report expressed no concerns.
  • Appointed Mangesh Vaze Chief Operating Officer and Senior Management Personnel, effective November 6, 2026.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.